Dr. Cohen’s Approach to Managing Double-hit Lymphoma

Get Permission

  • All patients with aggressive non Hodgkin lymphoma should be evaluated for MYC and BCL2/6 gene expression, if possible, by fluorescent in situ hybridization and immunohistochemistry.
  • Several intensive treatment regimens are available. Dr. Cohen favors dose-adjusted R-EPOCH for patients with double-hit lymphomas and for those classified as “double expressors.”
  • All patients should be assessed for central nervous system disease with strong consideration for prophylaxis.
  • Auto transplant’s role has not been established. Dr. Cohen recommends the pros and cons of stem cell transplant be discussed with each patient. ■

Related Articles

Double-Hit Lymphoma: Many Treatment Strategies, No Standard of Care

"Double-hit lymphoma” represents a challenging malignancy without a standard-of-care treatment, although outcomes for some patients are better than was once believed, according to Jonathon B. ­Cohen, MD, Assistant Professor of Hematology and Medical Oncology at Emory University, Atlanta. Dr. Cohen...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.